Liver graft injury caused by de novo donor-specific HLA antibodies in pediatric liver transplant recipients with low, moderate, and high immunologic risk-Reference-Cited by-同舟云学术

Liver graft injury caused by de novo donor-specific HLA antibodies in pediatric liver transplant recipients with low, moderate, and high immunologic risk

Published:2023-02 Issue:2 Volume:225 Page:275-281
ISSN:0002-9610
Container-title:The American Journal of Surgery
language:en
Short-container-title:The American Journal of Surgery

Author:

Liu Wei,Wang Zheng-Lu,Kang Zhong-Yu,Xiao Yan-Li,Liu Chun,Li Dai-Hong

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference37 articles.

1. Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation;O'Leary;Liver Transplant,2013

2. Association of post-transplant donor-specific HLA antibody with liver graft fibrosis during long-term follow-up after pediatric liver transplantation;Tokodai;Pediatr Transplant,2018

3. Humoral theory of transplantation;Terasaki;Am J Transplant,2003

4. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation;Musat;Am J Transplant,2011

5. High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection postliver transplant;O'Leary;Am J Transplant,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dimensional profiling of pediatric immune responses to solid organ transplantation;Cell Reports Medicine;2023-08

2. Mapping children by ALT 4–5 years after liver transplant: Potential individual and population applications;Pediatric Transplantation;2023-07-17

3. T‐cell infiltrate intensity is associated with delayed response to treatment in late acute cellular rejection in pediatric liver transplant recipients;Pediatric Transplantation;2023-01-23

4. Liver Transplantation from a Human Leukocyte Antigen-Matched Sibling Donor: Effectiveness of Direct-Acting Antiviral Therapy against Hepatitis C Virus Infection;Reports;2022-12-04